نتایج جستجو برای: myelogenous leukemia

تعداد نتایج: 284155  

Journal: :journal of mahani mathematical research center 0
esmail hesameddini department of mathematical sciences, shiraz university of technology, p. o. box 71555-313, shiraz, iran mahin azizi department of mathematical sciences, shiraz university of technology, p. o. box 71555-313, shiraz, iran

in this article, a mathematical model describing the growth orterminating myelogenous leukemia blood cancer's cells against naive t-celland e ective t-cell population of body, presented by fractional di erentialequations. we use this model to analyze the stability of the dynamics, whichoccur in the local interaction of e ector-immune cell and tumor cells. wewill also investigate the optima...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: the traditional goal of the treatment of acute myelogenous leukemia is to produce and maintain a complete remission (cr).the difference in survival time was entirely attributable to the duration of time spent in cr .in this study, the outcome of aml patients with allogeneic hsct in cr1 versus other than cr1 was compared. patients and methods: since march 1991 until november 2008, ...

Journal: :Journal of the National Comprehensive Cancer Network 2009

Journal: :Cancer research 1978
T Mohanakumar D S Miller J Anderson R S Metzgar

Nonhuman primate antisera defining leukemia-associ ated and normal Tand B-lymphocyte-associated anti gens were used to characterize serologically the cells from acute myelomonocytic leukemia (AMML) and chronic myelogenous leukemia patients in blast crisis (CML-BC). Earlier studies demonstrated that nonhuman primate an tisera to chronic lymphocytic leukemia, acute myelogen ous leukemia, and chro...

Journal: :Hamatologie und Bluttransfusion 1976
P S Sarin R C Gallo

High levels of terminal deoxynucleotidyl transferase have been observed in leukocytes of 7 out of 20 patients with chronic myelogenous leukemia in acute blast phase of the disease. These levels are comparable to the levels observed in human and calf thymus gland and cell lines with some T cell characteristics (Molt 4 and 8402). Negligible levels of this activity were observed in chronic myeloge...

Journal: :Cancer research 1975
A Durantez J Zighelboim T Thieme J L Fahey

Lymphocyte-dependent antibodies (LDA's) directed against antigenic determinants present on lymphoblastoid cell lines as well as human leukemia blast cells were demonstrated in heterologous antisera obtained by immunizing rabbits with a membrane fraction from RPMI-4265 (a lymphoblastoid cell line derived from a patient with chronic myelogenous leukemia). LDA was present at high titers against B-...

Journal: :Baylor University Medical Center Proceedings 2008

Journal: :Blood 1995
L Kapural M B Feinstein F O'Rourke A Fein

In normal human megakaryocytes, we identified a delayed rectifier type of voltage-gated outward K+ current (DRK). In two human megakaryoblastic tumor cell lines (DAMI, CHRF-288-11) and the human erythroleukemia cell line (HEL) the DRK current was not detected. To determine if the absence of the DRK current in the tumor cells is the result of the underlying malignant state, we examined megakaryo...

Journal: :Haematologica 2014
Husheng Ding Jennifer S McDonald Seongseok Yun Paula A Schneider Kevin L Peterson Karen S Flatten David A Loegering Ann L Oberg Shaun M Riska Shengbing Huang Frank A Sinicrope Alex A Adjei Judith E Karp X Wei Meng Scott H Kaufmann

Although farnesyltransferase inhibitors have shown promising activity in relapsed lymphoma and sporadic activity in acute myelogenous leukemia, their mechanism of cytotoxicity is incompletely understood, making development of predictive biomarkers difficult. In the present study, we examined the action of tipifarnib in human acute myelogenous leukemia cell lines and clinical samples. In contras...

Journal: :Blood 1952
H SHAY M GRUENSTEIN C HARRIS L GLAZER

AND LILLIAN GLAZER S CASES of lymphatic and 2 of myelogenous leukemia developed in a group of random bred Wistar rats in which methylcholanthrene was itsstilled into the stomach.5 Attempts were made to transfer each type of leakemia to 30 to 40 clay old rats of our colony with only indifferent success in lymphatic leukemia and complete failure to achieve any transfers its myelogenous leukemia. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید